Table 4.
GPR54 expression Positive (n = 30) | GPR54 expression Negative (n = 23) | P value | |
Recurrence, n (%) | 17 (56.7%) | 16 (69.6%) | 0.34 |
Site of recurrence | |||
Liver, n (%) | 8 (26.7%) | 7 (30.4%) | 0.76 |
Local, n (%) | 6 (20.0%) | 3 (13.0%) | 0.50 |
Peritoneum, n (%) | 5 (16.7%) | 4 (17.4%) | 0.95 |
Lymph nodes, n (%) | 2 (6.7%) | 3 (13.0%) | 0.43 |
Lungs, n (%) | 1 (3.3%) | 0 | 0.38 |
Bone, n (%) | 0 | 1 (4.3%) | 0.25 |
Unknown*, n (%) | 0 | 1 (4.3%) | 0.25 |
* Confirmed by elevated tumor marker during follow-up